Jonosteril Na 100 Mit Glucose

Magnesium chloride hexahydrate, potassium chloride, sodium chloride, calcium chloride dihydrate and glucose, the active ingredients in Jonosteril Na 100 Mit Glucose, are an electrolyte solution presented as a sterile solution for intravenous use. It is used for fluid and electrolyte replacement in patients who require intravenous therapy, such as during surgery or critical illness.

GNH USA supplies Jonosteril Na 100 Mit Glucose as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Jonosteril Na 100 Mit Glucose is an intravenous electrolyte solution used to manage fluid and electrolyte disorders. - Fluid and electrolyte replacement: restores extracellular fluid volume and corrects electrolyte deficits in patients receiving intravenous therapy. - Maintenance of hydration during surgery or critical illness: provides balanced electrolytes and glucose to support metabolic needs. - Correction of electrolyte imbalances: supplies sodium, potassium, calcium, magnesium and chloride to normalize serum levels. - Provision of glucose for energy: delivers glucose for patients unable to eat or absorb nutrients orally.

Adverse reactions may occur with any intravenous infusion and should be monitored.

Common Side Effects: - Infusion site pain or irritation - Mild hypernatremia - Mild hyperkalemia - Mild hypocalcemia - Transient increase in serum magnesium - Mild metabolic alkalosis

Serious or Rare Side Effects: - Severe hyperkalemia leading to cardiac arrhythmia - Severe hypernatremia causing neurologic dysfunction - Anaphylactic or severe hypersensitivity reaction - Electrolyte overload with pulmonary edema - Cardiac arrest due to electrolyte imbalance - Severe metabolic acidosis

Use of Jonosteril Na 100 Mit Glucose requires careful clinical assessment and monitoring. - Baseline electrolyte assessment: obtain serum electrolytes before initiation. - Renal impairment: adjust infusion rate and monitor renal function closely. - Cardiac disease: avoid rapid infusion in patients with heart failure or arrhythmias. - Neonates and infants: use reduced infusion rates and monitor electrolytes frequently. - Compatibility: do not mix with blood products or calcium‑containing solutions without proper protocols. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Electrolyte solutions can interact with other medications affecting ion balance.

Major Interactions (Avoid): - Concurrent potassium‑sparing diuretics: risk of severe hyperkalemia. - Calcium‑containing IV solutions mixed with blood products: precipitation risk. - Magnesium‑containing formulations with neuromuscular blocking agents: prolonged blockade. - High‑dose sodium bicarbonate: may cause excessive sodium load. - Hypertonic glucose solutions: risk of hyperglycemia.

Moderate Interactions (Monitor Closely): - Loop diuretics: may increase electrolyte losses, requiring adjustment. - ACE inhibitors or ARBs: can potentiate hyperkalemia. - NSAIDs: may affect renal handling of electrolytes. - Insulin therapy: glucose component may require insulin dose modification. - Corticosteroids: may alter sodium and potassium balance.